Cancer du sein associé à la grossesse
Tóm tắt
Từ khóa
Tài liệu tham khảo
Amant F, Deckers S, Van Calsteren K et al. (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46(18):3158–3168
Amant F, Van Calsteren K, Vergote I, Ottevanger N (2008) Gynecologic oncology in pregnancy. Crit Rev Oncol Hematol 67: 187–195
Andersson TM, Johansson AL, Hsieh CC et al. (2009) Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol 114:568–572.
Andrieu N, Goldgar DE, Easton DF, et al. (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98(8): 535–544
Antypas C, Sandilos P, Kouvaris J, et al. (1998) Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 40: 995–999
Aviles A, Neri N, Nambo MJ (2006) Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 17: 286–288
Beadle BM, Woodward WA, Middleton LP, et al. (2009) The impact of pregnancy on breast cancer outcomes in women ≤ 35 years. Cancer 1115(6): 1174–1184
Berkovitch M, Mazzota P, Greenberg R, et al. (2002) Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol 19: 311–316
Berry DL, Theriault RL, Holmes FA, et al. (1999) Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 17: 855–861
Briggs GC, Freeman RK, Yaffee SM (1998) A reference guide to fetal and neonatal risk: drugs in pregnancy and lactation. Lippincott Williams & Wilkins, Philadelphia
Clark RM, Reid J (1978) Carcinoma of the breast in pregnancy and lactation. Int J Radiat Oncol Biol phys 4:693–698
Einarson A, Maltepe C, Navioz Y, et al. (2004) The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 111: 940–943
Gentilini O, Cremonesi M, Trifirò G, et al. (2004) Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15(9): 1348–1351
Illidge TM, Hussey M, Godden CW (1996) Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol (R Coll Radiol) 8: 257–258
Ishida T, Yokoe T, Kasumi F, et al. (1992) Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 83(11): 1143–1149
Johannsson O, Loman N, Olsson H (1998) Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet 352: 1359–1360
Kal HB, Struikmans H (2005) Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 6: 328–333
Keleher A, Wendt R 3rd, Delpassand E, et al. (2004) The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 10(6): 492–495
Khera SY, Kiluk JV, Hasson DM, et al. (2008) Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 14(3): 250–254
Lambe M, Hsieh CC, Chan HW, et al. (1996) Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 38(3): 305–311
Largillier R, Savignoni A, Gligorov J, et al. (2009) Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged < 35 years: a GET(N)A Working Group analysis. Cancer 115(22): 5155–5165
Liberman L, Giess CS, Dershaw DD, et al. (1994) Imaging of pregnancy-associated breast cancer. Radiology 191(1): 245–248
Loibl S, Von Minckwitz G, Gwyn K, et al. (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106: 237–246
Mazonakis M, Damilakis J, Varveris H, et al. (1999) A method of estimating fetal dose during brain radiation therapy. Int J Radiat Oncol Biol Phys 44: 455–459
Mazonakis M, Varveris H, Damilakis J, et al. (2003) Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 55(2): 386–391
Mignot L (2002) Cancer of the breast and pregnancy: the point of view of the breast cancer specialist. Bull Cancer 89(9): 772–778
Minsker DH, Manson JM, Peter CP (1993) Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121: 217–223
Mir O, Berveiller P, Goffinet F, et al. (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 21(2): 425–426. Epub 2009 Nov 3
Mir O, Berveiller P, Ropert S, et al. (2008) Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 19: 607–613
Mir O, Berveiller P, Rouzier R, et al. (2008) Chemotherapy for breast cancer during pregnancy: is epirubicin safe? Ann Oncol 19: 1814–1815
Mondi MM, Cuenca RE, Ollila DW, et al. (2007) Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 14(1): 218–221
Navrozoglou I, Vrekoussis T, Kontostolis E, et al. (2008) Breast cancer during pregnancy: a mini-review. Eur J Surg Oncol 34(8): 837–843
Ngu SL, Duval P, Collins C (1992) Foetal radiation dose in radiotherapy for breast cancer. Australas Radiol 36: 321–322
Ní Mhuireachtaigh R, O’Gorman DA (2006) Anesthesia in pregnant patients for nonobstetric surgery. J Clin Anesth 18(1): 60–66
Ozer H, Armitage JO, Bennett CL, et al. (2000) American Society of Clinical Oncology. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 18: 3558–3585
Pandit-Taskar N, Dauer LT, Montgomery L, et al. (2006) Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med 47(7): 1202–1208
Pavlidis N, Pentheroudakis G (2005) The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev 31: 439–447
Ring AE, Smith IE, Jones A, et al. (2005) Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 23: 4192–4197
Rouzier R, Uzan S (2006) Place du traitement chirurgical des cancers du sein en cours de grossesse. 30e Journées nationales du Collège national des gynécologues obstétriciens français
Rouzier R, Werkoff G, Uzan C, et al. (2011) Pregnancy-associated breast cancer is as chemosensitive as classic breast cancer in the neoadjuvant setting. Into submission
Sabate JM, Clotet M, Torrubia S, et al. (2007) Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics 27(Suppl 1): S101–S124
Scott LL, Ramin SM, Richey M, et al. (1995) Erythropoietin use in pregnancy: two cases and a review of the literature. Am J Perinatol 12: 22–24
Shrim A, Garcia-Bournissen F, Maxwell C, et al. (2007) Favorable pregnancy outcome following Trastuzumab (Herceptin®) use during pregnancy. Case report and updated literature review. Reprod Toxicol 23: 611–613
Van der Giessen PH (1997) Measurement of the peripheral dose for the tangential breast treatment technique with Co-60 gamma radiation and high energy X-rays. Radiother Oncol 42: 257–264
Waalen J (1991) Pregnancy poses tough questions for cancer treatment. J Natl Cancer Inst 83(13): 900–902
Webb JA, Thomsen HS, Morcos SK, members of contrast media safety commitee of european society of urogenital radiology (ESUR) (2005) The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15:1234–4050.
White TT (1954) Carcinoma of the breast and pregnancy: analysis of 920 cases collected from the literature and 22 new cases. Ann Surg 139:9–18
Wilson S, Amsler K, Hyink D, et al. (2006) Inhibition of HER2/(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim Biophys Acta 1762: 647–655